-
Patient Advocates Go to Washington
Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.
by Marci A. Landsmann
-
The Affordable Care Act and Cancer Patients
Cancer survivors tell their stories and researchers take a broad view.
by Kevin McLaughlin
-
Forward Look
Inside the 21st Century Cures ActLegislation brings high hopes for cancer research.
by Stephen Ornes
-
Survivor Profile
Putting Her Armor OnAn acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
-
Q&A
Rolling Up Her SleevesPrincess Dina Mired of Jordan will be the first Arab president of the Union for International Cancer Control.
by Sue Rochman
-
Get Involved
Outdoor HealingAn outdoor adventure camp benefits cancer survivors of all ages.
by Lindsey Konkel
-
Forward Look
World Cancer Day: Accelerating ProgressImage courtesy of the Union for International Cancer Control February 4 is World Cancer Day, an international effort to increase cancer awareness and education to reduce preventable cancer deaths. World Cancer Day 2017 marks the midpoint of a three-year campaign, “We Can. I Can.” The overarching goal has been to encourage everyone, everywhere—from government health organizations […]
by Sue Rochman
-
Screening Gets Personal
Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?
by Kate Yandell
-
Survivor Profile
Going Full BoreSusan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.
by Sue Rochman
-
Get Involved
Diversifying DonorsA diverse donor pool benefits patients in need of bone marrow transplants.
by Lindsey Konkel
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona